Decentralized Cochlear Implant Programming Network Improves Access, Maintains Quality, and Engenders High Patient Satisfaction

2021 ◽  
Vol 42 (8) ◽  
pp. 1142-1148
Author(s):  
Stephanie Bourn ◽  
Mary Rose Goldstein ◽  
Alissa Knickerbocker ◽  
Abraham Jacob
Author(s):  
Ravindra Bharathi ◽  
Praveen Bhardwaj ◽  
Vigneswaran Varadharajan ◽  
Hari Venkatramani ◽  
S Raja Sabapathy

AbstractReplantation of digital amputations is now the accepted standard of care. However, rarely will a replantation surgeon be presented with amputated fingers which have been previously replanted. In our literature search, we could find only one publication where a replanted thumb suffered amputation and was successfully replanted again. We report the technical challenges and the outcome of replanting two fingers which suffered amputation 40 months after the initial replantation and were successfully replanted again. Replantation was critical since the amputated fingers were the only two complete fingers in that hand which had initially suffered a four-finger amputation. The second-time replantation of previously replanted fingers is reported to allay the concern of the reconstructive surgeon when faced with this unique situation of “repeat amputation of the replanted finger.” Second-time replantation is feasible and is associated with high-patient satisfaction. Replantation must be attempted especially in the event of multiple digit amputations.


2016 ◽  
Vol 17 (1) ◽  
Author(s):  
Petter Morten Pettersen ◽  
Joakim Eriksson ◽  
Hallgeir Bratberg ◽  
Lars Eldar Myrseth ◽  
Lise Grete Bjørnstad ◽  
...  

2007 ◽  
Vol 63 (1) ◽  
pp. 94-95 ◽  
Author(s):  
Ninaad S. Awsare ◽  
James A. Green ◽  
Beverley Aldwinckle ◽  
Damian C. Hanbury ◽  
Greg B. Boustead ◽  
...  

2014 ◽  
Vol 04 (11) ◽  
pp. 263-275
Author(s):  
Ulrike Reuter ◽  
Babette Jurack ◽  
Nils Engelmann ◽  
Thilo Busch ◽  
Joerg Schnoor

2007 ◽  
Vol 17 (5_suppl) ◽  
pp. 28-30 ◽  
Author(s):  
C. Migdal

Several fixed combination products are now available in glaucoma management. Considerations when selecting combination therapy include safety, finding the best combination of mechanisms of action. Combigan® is one such product that has been shown to be more effective than either of its constituent agents, brimonidine or timolol, used alone. It has at least a similar intraocular pressure (IOP)-lowering effect as the concomitant use of its two constituents, and it produces a significant additional lowering of IOP in patients who switch from other therapies, including Cosopt®. Combigan has high patient satisfaction ratings.


Sign in / Sign up

Export Citation Format

Share Document